Register
Login:
Share:
Email Facebook Twitter

Add Scancell Holdings to quick picks

Scancell Holdings Share Price (SCLP)



Share Price Information for Scancell Holdings (SCLP)


Share Price: 34.75Bid: 34.00Ask: 35.50Change: 0.00 (0.00%)No Movement on Scancell Hldgs
Spread: 1.50Spread as %: 4.41%Open: 33.75High: 34.75Low: 33.75Yesterday’s Close: 34.75
InfoGet Live Streaming Prices for SCLP - Click here to start your 30 day FREE trial today.


Scancell Holdings Plc Ord 0.1P

Scancell Holdings is listed in the FTSE AIM All-Share
Scancell Holdings is part of the Pharmaceuticals & Biotechnology sector




Intraday Scancell Holdings Share Chart




Share Price SpacerPrice
34.75

Share Price SpacerBid
34.00

Share Price SpacerAsk
35.50

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
197,334

Share Price SpacerOpen
33.75

Share Price SpacerHigh
34.75

Share Price SpacerLow
33.75

Share Price SpacerClose
34.75

Share Price SpacerCurrency
GBX

3 Month Scancell Holdings Share Graph




Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 224.95m £78.17m 15,000

52 Week High 46.25 52 Week High Date 9-DEC-2013
52 Week Low 27.00 52 Week Low Date 13-NOV-2013

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
22 10,145 187,189 -35.459 -0.98 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

01-Sep-14
16:27:49
35.00
100,000
Buy* 
34.00
35.50
35.00k
Trade Type:
Ordinary

01-Sep-14
17:09:29
34.75
85,000
 
34.00
35.50
29.54k
Trade Type:
Ordinary

01-Sep-14
16:28:14
34.92
6,832
Buy* 
34.00
35.50
2,386
Trade Type:
Ordinary
Bargain conditions apply


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Scancell Holdings trades >>

Directors Deals for Scancell Holdings (SCLP)
Trade DateActionNotifierPriceCurrencyAmountHolding
10-Dec-13Notification of Holding
Trade Notifier Information for Scancell Holdings
Lindy Durrant held the position of CEO at Scancell Holdings at the time of this trade.
 Lindy Durrant
000
10-Dec-13Notification of Holding
Trade Notifier Information for Scancell Holdings
Richard Goodfellow held the position of Joint CEO at Scancell Holdings at the time of this trade.
 Richard Goodfellow
000
21-Oct-13Sell
Trade Notifier Information for Scancell Holdings
Lindy Durrant held the position of CEO at Scancell Holdings at the time of this trade.
 Lindy Durrant
30GBX100,0000
View more Scancell Holdings directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
Mon 23:08
TorquayFan
G'morning
34.75
No Opinion

and thanks everyone. A really good BB today and Konar, why the sabbatical ? Regarding 'outright sale' or not ? I think it quite probable that at least one Pharma CEO, will have a 'penny drop' moment and take the lot at a handsome price - or at least, ALL of Immunobody. GLA and nice to see the SP creeping up again.
Mon 23:05
krafty1305
RE: Goy/Bibio
34.75
Strong Buy

Lindy explained to us they are different products for different purposes
Mon 22:13
boomorbust
RE: Goy/Bibio
34.75
No Opinion

Konar, agree that in the long term that's where SCIB1 seems to sit but there is obviously a reason why Scancell have trialled the 8mg patients with tumour load and also carried out the PD-1 research. Perhaps this would be a quicker route to approval and market as clinical response is quickly and easily measured as opposed to using survival stats on earlier stage patients. Goy - my feeling is also that an outright sale would be the BOD's preference but I know many others think otherwise. Either way it will be fascinating to watch it all unfold.
Mon 22:01
Goyathlay
RE: Goy/Bibio
34.75
No Opinion

Thanks for that. Yes, I was suggesting that Moditope may supersede the combination but I concede your point as to the timing of the development and the invested capital. Just curious as to the stage of the research that justified the claim that Moditope worked without checkpoint inhibitors, as the additivity for the combination has only been demonstrated recently in the murine model. I suppose a buyer would have to ask himself whether he wanted to buy the revolutionary Iphone 3 which sadly doubles as an X ray machine and interferes with Radio 4 reception or would he want to wait for the Iphone 7 the definitive expression of the technology. Best to scoop up both and not run the risk of a competitor doing so. Company sale for my money
Mon 22:01
KonarA
RE: Goy/Bibio
34.75
Strong Buy

Just returning temporarily from my self imposed sabbatical, to give a couple of my thoughts on Moditope. Firstly, I don't see SCIBs, Combinations and Moditope as competing against each other. I think they will be different treatments, for patients at different stages of disease progression. I can see SCIB, with its benign side effect profile being given pretty much at the point of diagnosis, and routinely after that. This will give the patient the best opportunity to mount a strong immune response. If and when the patient starts to show signs of disease progression (i.e. tumor load) then a checkpoint inhibitor (with its slightly more risky side effect profile) will be given in combination to overcome resistance. Moditope requires a stressed tumor - so any patient that has either bypassed treatment options above (late diagnosis); or disease has progressed beyond above treatment options; or failed to respond to above treatment options - will be given Moditope. So, as i said, i don't see these as competing products, just more options for clinicians. My second point on Moditope, is that I always ruled out a complete sale of the company because Immunobody was approaching the point of being ready for sale, whilst Modi1 wasn't due to be ready for the clinic until 2016. With the (unofficial) news that Modi 1 trial is ready to go - does the out and out sale become a more realistic option? Anyways that is all from me, back to my sabbatical.
Mon 21:50
Wildforce
Exciting next 10 years
34.75
Strong Buy

Imagine - an immunobody vaccine loaded with modified epitopes working in conjunction with check point Inhibitors ... sounds like a very powerful combination to me !! Everyone wins !! Take care all ... (Just my thoughts as ever!) ....

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Scancell Holdings (SCLP) >>
Please Login or Register to post messages

Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs




Sign up for Live Prices


CD02WL.001.081313
Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.